NRC-2694 |
Catalog No.GC33131 |
NRC-2694는 항암 및 항증식 특성을 가진 표피 성장 인자 수용체(EGFR) 길항제입니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 936446-61-6
Sample solution is provided at 25 µL, 10mM.
NRC-2694 is an epidermal growth factor receptor (EGFR) antagonist with anti-cancer and anti-proliferative properties.
NRC-2694 at 80 ng (190 nm) concentrations causes comparable inhibition of EGFR expression[1].
In toxicity studies, the maximum tolerated dose of NRC-2694 in male and female mice is 2000 mg/kg (po). NRC-2694 (10 mg/kg) regresses the tumor in mice[1].
[1]. Ramanadham Jyothi Prasad, et al. 6-7,dialkoxy quinazoline derivatives useful for treatment of cancer related disorders. US 8143250 B2
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *